Glaxosmithkline Pharmaceuticals has reported results for third quarter ended December 31, 2019.
The company has reported a net loss of Rs 644.14 crore for the quarter under review against net profit of Rs 112.97 crore for the same quarter in the previous year. Total income of the company decreased by 5.56% at Rs 794.93 crore for Q3FY20 as compared Rs 841.77 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a net loss of Rs 661.16 crore for the quarter under review against net profit of Rs 113.67 crore for the same quarter in the previous year. Total income of the company decreased by 5.56% at Rs 795.09 crore for Q3FY20 as compared Rs 841.93 crore for the corresponding quarter previous year.
